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CYTOCHROME P450S AND USES THEREOF

fore concluded that the 3-hydroxylase, responsible for
hydroxylation of 5-epi-aristolochene at C3 to generate
1-deoxycapsidiol, was pathogen/elicitor inducible, while the

RELATED APPLICATIONS

1-hydroxylase, responsible for hydroxylating 1-deoxycap
sidiol at the C1 to generate capsidiol, was constitutive.

This application is a continuation of US. patent applica
tion Ser. No. 12/182,000, ?led Jul. 29, 2008, now US. Pat.
No. 8,263,362 which is a continuation of US. patent appli
cation Ser. No. 10/097,559, ?led Mar. 8, 2002 (now issued
US. Pat. No. 7,405,057), which claims the bene?t of US.

Hoshino et al. (Phytochemistry 38:609-613, 1995) added to
the observations of Whitehead et al. (Phytochemistry 28:775

779, 1989) by directly measuring 3-hydroxylase-activity in
microsomal preparations of arachidonic acid-elicited Capsi
cum annuum fruits and seedlings. These assays consisted of

Provisional Application Nos. 60/274,421 and 60/275,597,
?led on Mar. 9, 2001 and Mar. 13, 2001, respectively, all of

incubating 5-epi-aristolochene with microsome preparations

which are hereby incorporated by reference.

and subsequently determining the amount of 1-deoxycapsid
iol generated by a combination of thin-layer chromatography
(TLC) separations and gas chromatography (GC). Their evi

FIELD OF THE INVENTION

dence demonstrated that the conversion of 5-epi-aris
This invention relates to cytochrome P450s and uses
thereof.

tolochene to 1-deoxycapsidiol was dependent on both

NADPH and 02, and that 1-deoxycapsidiol accumulation
in vitro was arrested by the P450 antagonists carbon monox

BACKGROUND OF THE INVENTION

ide (Omura and Sato, J. Biol. Chem. 239:2370-2378, 1964),
20

Cytochrome P450s encompass a superfamily of oxidases
responsible for the oxidation of numerous endobiotics and

thousands of xenobiotics. In addition, in plants, cytochrome
P450s play important roles in wound healing, pest resistance,
signaling, and anti-microbial and anti-fungal activity.
Capsidiol is a bicyclic, dihydroxylated sesquiterpene pro

1978), and ketoconazole (Rademacher, Arum. Rev. Plant

Physiol. Plant Mol. Biol. 51:501-531, 2000).
Recent results suggest that the hydroxylation of 5-epi
aristolochene is an important regulated step in capsidiol bio
25

duced by many Solanaceous species in response to a variety
of environmental stimuli, including exposure to UV (Back et

al., Plant Cell. Physiol. 389:899-904, 1998) and infection by
microorganisms (Molot et al., Physiol. Plant Pathol. 379-389,
1981; Stolle et al., Phytopathology 78:1193-1197,1988;
Keller et al., Planta. 205:467-476, 1998). It is the primary

ancymidol (Coolbaugh et al., Plant Physiol. 62:571-576,

synthesis. In studies to evaluate the effectiveness of methyl
jasmonate as an inducer ofcapsidiol biosynthesis in tobacco

cell cultures, Mandujano-Chavez et al. (Arch. Biochem. Bio
phys. 381 :285-294, 2000), reported that the modest accumu
lation of this phytoalexin was accompanied by a strong induc
30

tion of EAS. This result implied that steps before or after the

sesquiterpene cyclase reaction were limiting. Using an in vivo
assay measuring the conversion rate of radiolabeled 5-epi

antibiotic or phytoalexin produced in tobacco in response to

aristolochene to capsidiol, a very limited induction of the

fungal elicitation, and it is derived from the isoprenoid path
way via its hydrocarbon precursor, 5-epi-aristolochene (FIG.
1). Several of the biosynthetic enzymes leading up to 5-epi

hydroxylase activity was observed in cells treated with
35

cells. This result pointed to the hydroxylase reactions as a

aristolochene formation have been studied (Chappell, Annu.
Rev. Plant Physiol. Plant Mol. Biol. 46:521-547, 1995), espe

potentially limiting step in capsidiol biosynthesis.

cially 5-epi-aristolochene synthase (BAS) (Vogeli and Chap
pell, Plant Physiol. 88: 1291 -1296, 1988; Back and Chappell,

SUMMARY OF THE INVENTION
40

In one aspect, the invention features several isolated cyto

Proc. Natl. Acad. Sci. USA. 93:6841-6845, 1996; Mathis et

al., Biochemistry 36:8340-8348, 1997; Starks et al., Science
277: 1815-1820, 1997). BAS commits carbon to sesquiter
pene metabolism by catalyzing the cyclization of famesyl
diphosphate (FPP) to 5-epi-aristolochene. However, until the
present invention, the enzyme(s) responsible for the conver
sion of 5-epi-aristolochene to capsidiol has yet to be fully

chrome P450 polypeptides (such as CYP71D20, CYP71D21,
CYP73A27, CYP73A28, and CYP92A5, and P450s having
45

identi?ed and characterized.
Biochemical evidence from previous studies in tobacco

(Whitehead et al., Phytochemistry 28:775-779, 1989) and
green pepper (Hoshino et al., Phytochemistry 38:609-613,
1995) have suggested that the oxidation of 5-epi-aris

50

substantial identity to these polypeptides), as well as isolated
nucleic acid molecules that encode these P450s.
In related aspects, the invention features a vector (such as
an expression vector) including an isolated nucleic acid mol
ecule of the invention and a cell (for example, a prokaryotic
cell, such as Agrobacterium or E. coli, or a eukaryotic cell,

such as a mammalian, insect, yeast, or plant cell) including
the isolated nucleic acid molecule or vector.

tolochene to capsidiol occurs in a two step process with one of

the hydroxylation steps being constitutive and the other being
mediated by an elicitor-inducible cytochrome P450

methyl jasmonate relative to that in fungal elicitor-treated

55

In yet another aspect, the invention features a transgenic
plant or transgenic plant component including a nucleic acid
molecule of the invention, wherein the nucleic acid molecule
is expressed in the transgenic plant or the transgenic plant

(FIG. 1). Because 1-deoxycapsidiol had been isolated from

component. Preferably, the transgenic plant or transgenic

natural sources (Watson et al., Biochem. Soc. Trans. 11:589,

plant component is an angiosperm (for example, a monocot or

1983), Whitehead et al. (Phytochemistry 28:775-779, 1989),

dicot). In preferred embodiments, the transgenic plant or
transgenic plant component is a solanaceous, maize, rice, or

surmised that perhaps the biosynthesis of this intermediate
was due to pathogen induction of a corresponding hydroxy

60

lase. They therefore prepared synthetic 1-deoxycapsidiol and
reported a modest conversion of this compound to capsidiol

In another aspect, the invention features a method of pro
viding an increased level of resistance against a disease

when fed to control or unelicited tobacco cell cultures. This

was further supported by their observation that radiolabeled
5-epi-aristolochene was only converted to capsidiol when fed

cruciferous plant or a component thereof. The invention fur

ther includes a seed produced by the transgenic plant or
transgenic plant component, or progeny thereof.

65

caused by a plant pathogen in a transgenic plant. The method

to elicitor-induced cell cultures but not control cultures.

involves: (a) producing a transgenic plant cell including the

Whitehead et al. (Phytochemistry 28:775-779, 1989) there

nucleic acid molecule of the invention integrated into the

US 8,445,231 B2
3

4

genome of the transgenic plant cell and positioned for expres
sion in the plant cell; and (b) growing a transgenic plant from
the plant cell wherein the nucleic acid molecule is expressed

tively). Forpolypeptides, the length of comparison sequences
will generally be at least 16 amino acids, preferably at least 20
amino acids, more preferably at least 25 amino acids, and
most preferably 35 amino acids. For nucleic acids, the length
of comparison sequences will generally be at least 50 nucle
otides, preferably at least 60 nucleotides, more preferably at
least 75 nucleotides, and most preferably 110 nucleotides.

in the transgenic plant and the transgenic plant is thereby
provided with an increased level of resistance against a dis
ease caused by a plant pathogen.
In another aspect, the invention features a method for pro

Sequence identity is typically measured using sequence
analysis software (for example, Sequence Analysis Software

ducing an altered compound, the method including the steps
of contacting the compound with one or more of the isolated

Package of the Genetics Computer Group, University of Wis
consin Biotechnology Center, 1710 University Avenue,

polypeptides disclosed herein under conditions allowing for
the hydroxylation, oxidation, demethylation, or methylation
of the compound and recovering the altered compound.

Madison, Wis. 53705, BLAST, or PILEUP/PRETTYBOX

In still another aspect, the invention features a hydroxylat

programs). Such software matches identical or similar

ing agent including any of the isolated polypeptides disclosed

sequences by assigning degrees of homology to various sub
stitutions, deletions, and/or other modi?cations. Conserva

herein.
In yet another embodiment, the invention features an iso

lated nucleic acid molecule that speci?cally hybridizes under
highly stringent conditions to the complement of any one of
the sequences described in SEQ ID N012 (CYP71D20), SEQ
ID N014 (CYP71D21), SEQ ID N016 (CYP73A27), SEQ ID
N018 (CYP73A28), or SEQ ID N0112 (CYP92A5), wherein

tive substitutions typically include substitutions within the

following groups: glycine, alanine; valine, isoleucine, leu
20

By an “isolated polypeptide” is meant a P450 polypeptide

such a nucleic acid molecule encodes a cytochrome P450

polypeptide.
In another aspect, the invention features a host cell express

ing a recombinant isoprenoid synthase and a recombinant

25

cytochrome P450. In preferred embodiments, the host cell
further expresses, independently or in combination, a recom

binant acetyltransferase, methyltransferase, or fatty acyl
transferase. In other preferred embodiments, the host
expresses an endogenous or recombinant cytochrome reduc
tase. Preferably, the host cell is a yeast cell, a bacterial cell, an
insect cell, or a plant cell.
In a related aspect, the invention features a method for

30

producing an isoprenoid compound, the method including the
steps of: (a) culturing a cell that expresses a recombinant

analysis.
40

By “derived from” or “obtained from” is meant isolated
from or having the sequence of a naturally-occurring

sequence (e.g., cDNA, genomic DNA, synthetic, or combi
nation thereof).

acetyltransferase, a recombinant methyltransferase, or a

recombinant fatty acyltransferase. In other preferred embodi

By “isolated nucleic acid molecule” is meant a nucleic acid
molecule, e.g., a DNA molecule, that is free of the nucleic

ments, the host cell expresses an endogenous or recombinant
45

acid sequence(s) which, in the naturally-occurring genome of

50

the organism from which the nucleic acid molecule of the
invention is derived, ?ank the nucleic acid molecule. The
term therefore includes, for example, a recombinant DNA
that is incorporated into a vector; into an autonomously rep
licating plasmid or virus; or into the genomic DNA of a

a bacterial cell, an insect cell, or a plant cell.

In yet another aspect, the invention features an isoprenoid

compound produced according to the above-mentioned
methods.

By “P450 polypeptide,” “cytochrome P450,” or “P450” is

chemically synthesizing the protein. Purity can be measured

by any appropriate method, for example, column chromatog
raphy, polyacrylamide gel electrophoresis, or by HPLC

embodiments, the host cell further expresses a recombinant

cytochrome reductase. Preferably, the host cell is a yeast cell,

(for example, a CYP71D20 (SEQ ID N011), CYP71D21
(SEQ ID N013), CYP73A27 (SEQ ID N015), CYP73A28
(SEQ ID N017), or CYP92A5 (SEQ ID N011 1) polypeptide)
that has been separated from components that naturally
accompany it. Typically, the polypeptide is isolated when it is
at least 60%, by weight, free from the proteins and naturally
occurring organic molecules with which it is naturally asso
ciated. Preferably, the preparation is at least 75%, more pref
erably at least 90%, and most preferably at least 99%, by
weight, a P450 polypeptide. An isolated P450 polypeptide
may be obtained, for example, by extraction from a natural
source (for example, a plant cell); by expression of a recom
binant nucleic acid encoding a P450 polypeptide; or by
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isoprenoid synthase and a recombinant cytochrome P450
under conditions wherein the isoprenoid synthase and the
cytochrome P450 are expressed and catalyze the formation of

an isoprenoid compound not normally produced by the cell;
and (b) recovering the isoprenoid compound. In preferred

cine; aspartic acid, glutamic acid, asparagine, glutamine;
serine, threonine; lysine, arginine; and phenylalanine,
tyrosine.

meant a polypeptide that contains a heme-binding domain
and shows a C0 absorption spectra peak at 450 nm according

prokaryote or eukaryote; or that exists as a separate molecule
(for example, a cDNA or a genomic or cDNA fragment pro

to standard methods, for example, those described herein.
Such P450s may also include, without limitation, hydroxy

duced by PCR or restriction endonuclease digestion) inde
pendent of other sequences. The term “isolated nucleic acid
molecule” also includes a recombinant DNA which is part of

lase activity, dual hydroxylase activity, demethylase activity,

55

a hybrid gene encoding additional polypeptide sequences.
By “speci?cally hybridizes” is meant that a nucleic acid

or oxidase activity. Such enzymatic activities are determined
using methods well known in the art.

By “polypeptide” is meant any chain of amino acids,

sequence is capable of hybridizing to a DNA sequence at least

regardless of length or post-translational modi?cation (for
example, glycosylation or phosphorylation).

under low stringency conditions, and preferably under high
stringency conditions. For example, high stringency condi

60

tions may include hybridization at approximately 42° C. in
about 50% forrnamide, 0.1 mg/ml sheared salmon sperm
DNA, 1% SDS, 2><SSC, 10% Dextran sulfate, a ?rst wash at
approximately 65° C. in about 2><SSC, 1% SDS, followed by

By “substantially identical” is meant a polypeptide or
nucleic acid exhibiting at least 80 or 85%, preferably 90%,
more preferably 95%, and most preferably 97%, or even 98%
identity to a reference amino acid sequence (for example, the

amino acid sequence shown in SEQ ID NOS11, 3, 5, 7 and 11)
or nucleic acid sequence (for example, the nucleic acid
sequences shown in SEQ ID NOS12, 4, 6, 8 and 12, respec

65

a second wash at approximately 650 C. in about 0.1><SSC.

Alternatively high stringency conditions may include hybrid
ization at approximately 420 C. in about 50% forrnamide, 0.1

US 8,445,231 B2
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mg/ml sheared salmon sperm DNA, 0.5% SDS, 5><SSPE,

By “pathogen” is meant an organism whose infection of
viable plant tissue elicits a disease response in the plant tissue.

1><Denhardt’s, followed by two washes at room temperature
in 2><SSC, 0.1% SDS, and two washes at between 55-600 C.

Such pathogens include, without limitation, bacteria, myco
plasmas, fungi, insects, nematodes, viruses, and viroids. Plant

in 0.2><SSC, 0.1% SDS. Reducing the stringency of the
hybridization conditions may involve lowering the wash tem

diseases caused by these pathogens are described in Chapters

perature and/ or washing at a higher concentration of salt. For

11-16 ongrios,
Plant Pathology, 3rd ed., Academic Press, Inc., New York,

example, low stringency conditions may include washing in
2><SSC, 0.1% SDS at 40° C.
By “transformed cell” is meant a cell into which (or into an
ancestor of which) has been introduced, by means of recom

1 988.
By “increased level of resistance” is meant a greater level
of resistance to a disease-causing pathogen in a transgenic

binant DNA techniques, a DNA molecule encoding (as used
herein) a P450 polypeptide.
By “positioned for expression” is meant that the DNA

plant (or cell or seed thereof) of the invention than the level of
resistance relative to a control plant (for example, a non

transgenic plant). In preferred embodiments, the level of

molecule is positioned adjacent to a DNA sequence which

resistance in a transgenic plant of the invention is at least 20%
(and preferably 30% or 40%) greater than the resistance of a

directs transcription and translation of the sequence (i.e.,
facilitates the production of, for example, a P450 polypeptide,

control plant. In other preferred embodiments, the level of

a recombinant protein, or an RNA molecule).

resistance to a disease-causing pathogen is 50% greater, 60%

By “reporter gene” is meant a gene whose expression may

greater, and more preferably even 75% or 90% greater than a

be assayed; such genes include, without limitation, beta-glu

curonidase (GUS), luciferase, chloramphenicol transacety
lase (CAT), green ?uorescent protein (GFP), beta-galactosi

20

dase, herbicide resistant genes, and antibiotic resistance
genes.

By “expression control region” is meant any minimal
sequence suf?cient to direct transcription. Included in the

25

invention are promoter elements that are suf?cient to render

promoter-dependent gene expression controllable for cell-,
tissue-, or organ-speci?c gene expression, or elements that

are inducible by external signals or agents (for example,
light-, pathogen-, wound-, stress-, or hormone-inducible ele

2,2-dichloro isonicotinic acid (lNA)); such elements may be
located in the 5' or 3' regions of the native gene or engineered
into a transgene construct.
35

sequence(s) are connected in such a way as to permit gene

organic molecules with which it is naturally associated. Pref
erably, the preparation is at least 75%, more preferably 90%,
and most preferably at least 99%, by weight, antibody, for
example, an acquired resistance polypeptide-speci?c anti
body. A puri?ed P450 antibody may be obtained, for

produced P450 polypeptide and standard techniques.

transcriptional activator proteins) are bound to the regulatory

By “speci?cally binds” is meant an antibody which recog

sequence(s).
40

ing a plastid. Such a cell also requires a cell wall if further

propagation is desired. Plant cell, as used herein includes,

without limitation, algae, cyanobacteria, seeds, suspension
cultures, embryos, meristematic regions, callus tissue, leaves,
roots, shoots, gametophytes, sporophytes, pollen, and

60%, by weight, free from proteins and naturally-occurring

example, by af?nity chromatography using a recombinantly

expression when the appropriate molecules (for example,
By “plant cell” is meant any self-propagating cell bounded
by a semi-permeable membrane and typically is one contain

mined by comparing physical features and characteristics (for
example, plant height and weight, or by comparing disease
symptoms, for example, delayed lesion development,
reduced lesion size, leaf wilting and curling, water-soaked
spots, and discoloration of cells) of transgenic plants.
By “puri?ed antibody” is meant antibody which is at least

30

ments or chemical inducers such as salicylic acid (SA) or

By “operably linked” is meant that a gene and a regulatory

control plant; with up to 100% above the level of resistance as
compared to a control plant being mo st preferred. The level of
resistance is measured using conventional methods. For
example, the level of resistance to a pathogen may be deter

45

nizes and binds a P450 protein but which does not substan

tially recognize and bind other molecules in a sample, for
example, a biological sample, which naturally includes a
P450 protein such as CYP71D20, CYP71D21, CYP73A27,
CYP73A28, or CYP92A5. Other features and advantages of
the invention will be apparent from the following description
of the preferred embodiments thereof, and from the claims.

microspores.
By “plant component” is meant a part, segment, or organ
obtained from an intact plant or plant cell. Exemplary plant

components include, without limitation, somatic embryos,
leaves, stems, roots, ?owers, tendrils, fruits, scions, and root

BRIEF DESCRIPTION OF THE DRAWINGS
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stocks.

By “transgene” is meant any piece of DNA which is
inserted by arti?ce into a cell and typically becomes part of
the genome, for example, the nuclear or plastidic genome, of
the organism which develops from that cell. Such a transgene
may include a gene which is partly or entirely heterologous
(i.e., foreign) to the transgenic organism, or may represent a
gene homologous to an endogenous gene of the organism.
By “transgenic” is meant any cell which includes a DNA
sequence which is inserted by arti?ce into a cell and becomes
part of the genome of the organism which develops from that
cell. As used herein, the transgenic organisms are generally

FIG. 1 is a schematic diagram of a proposed alternative

pathway for the biosynthesis of capsidiol in elicitor-treated
Nicoliana labacum cells. 5-epi-aristolochene is synthesized
from FPP by the action of a sesquiterpene cyclase, 5-epi

aristolochene synthase (EAS), and is subsequently hydroxy
55

lated at C1 and C3 to form capsidiol.
FIG. 2 is a graph showing an induction time course for

sesquiterpene cyclase enzyme activity and sesquiterpene
hydroxylase activity in cellulase-treated cell cultures. Ses

quiterpene cyclase (5-epi-aristolochene synthase, EAS)
60

enzyme activity was determined in extracts prepared from

control (open squares) and elicitor-treated (closed squares)
cells collected at the indicated time points. Sesquiterpene
hydroxylase activity was determined using an indirect assay

transgenic plants and the DNA (transgene) is inserted by

for control (open circles) and elicitor-treated (closed circles)

plant according to the invention may contain one or more

cells. Cell cultures were incubated with [3H]-5-epi-aris
tolochene for 3 hours ending at the indicated time points

engineered traits.

before quantifying the incorporation of radioactivity into

arti?ce into the nuclear or plastidic genome. A transgenic

65
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extracellular capsidiol, a dihydroxylated form of aris
tolochene (Mandujano-Chavez et al., Arch. Biochem. Bio

the epoxidation of these substrates (Hallahan et al., Biochim.

Biophys. Acta. 1201194-100, 1994). MsCYP71D18
(AAD44150) and MpCYP71D13 (AAD44151) catalyze the

phys. 381 1285-294, 2000).
FIG. 3 is a series of graphs showing the dose dependent

mono-hydroxylation at C6 and C3 of limonene, a cyclic

inhibition of 5-epi-aristolochene hydroxylase activity by

monoterpene, respectively (Lupien et al., Arch. Biochem.

ancymidol and ketoconazole. Cell cultures were incubated in
the presence of cellulase (0.5p.g/ml) plus the indicated con
centrations of ancymidol (A) or ketoconazole (B) for 12 hours

Biophys. 3681181-192, 1999). AtCYP701A3 (AAC39505)
encodes for kaurene oxidase, which catalyzes a 3-step reac
tion including a hydroxylation followed by oxidation of a

prior to measuring the in vivo 5-epi-aristolochene hydroxy

diterpene (Helliwell et al., Plant Physiol. 1191507-510,

lase activity in the cell suspension cultures (squares), or the
EAS enzyme activity in extracts prepared from the collected
cells (triangles). The in vitro activity of a puri?ed EAS prepa
ration (Back and Chappell, J. Biol. Chem. 27017375-7381,

1999). Shown are sequences from Menlha piperila

(MpCYP71D13; SEQ ID N0139), Menlha spicala
(MsCYP71D18; SEQ ID N0140), Nepela racemosa
(NrCYP71A5v1; SEQ ID N0141), Nicoliana tabacum
(NtCYP71D20; SEQ ID N011), Persea americana
(PaCYP71A1; SEQ ID N0142), and Arabidopsis Zhaliana

1995) was also measured at the indicated inhibitor concen
trations as an additional test for non-speci?c effects of these

inhibitors (circles).

(CYP701A3; SEQ ID N0143). Conserved residues are

FIG. 4A is a schematic diagram of the primary structure of
a generalized cytochrome P450 with conserved domains used

shaded.

for the design of PCR primers highlighted (SEQ ID NOS126

29).

DETAILED DESCRIPTION
20

FIG. 4B is a list of the degenerate P450-speci?c primers
(SEQ ID NOS130-36) that were used in various combinations

Capsidiol is a bicyclic, dihydroxylated sesquiterpene pro
duced by several Solanaceous species in response to a variety
of environmental stimuli. It is the primary antimicrobial com

with vector speci?c primers in the ampli?cation of cyto
chrome P450 cDNA fragments.
FIG. 4C is a scanned image of an ethidium bromide-stained

25

agarose gel showing the PCR products ampli?ed from a
directional cDNA library prepared with mRNA isolated from
elicitor-treated cells using the degenerate primer GRRXCP

(A/G)- for (SEQ ID N0135) and the T7 vector-speci?c primer
(SEQ ID N0137). The T3 vector-speci?c primer is also shown

30

(SEQ ID N0138).
FIG. 5 is a series of Northern blots showing the induction
time course for CYP71D, CYP73A, CYP82E, CYP92A, and
EAS transcript accumulation in elicitor treated cells. Total
RNA was extracted from tobacco suspension cells incubated
with the cellulase elicitor for the indicated durations, size

35

chrome P450 enzymes. Using degenerate oligonucleotide
primers designed to the well-conserved domains found
within most P450 enzymes, including the heme binding
domain, cDNA fragments representing four distinct P450

conditions, and transferred to a nylon membrane before prob

families (CYP71, CYP73, CYP82, and CYP92) were ampli
40

FIG. 6 is a series of graphs showing carbon monoxide (C0)
difference spectra of the microsomal fraction isolated from

yeast expressing the CYP92A5 (A) and CYP71D20 (B)
cDNAs. Expression of the respective plasmid constructs

capsidiol.
Accordingly, an in vivo assay for 5-epi-aristolochene
hydroxylase-activity was developed and used to demonstrate
a dose dependent inhibition of activity by ancymidol and
ketoconazole, two well-characterized inhibitors of cyto

fractionated by agarose gel electrophoresis under denaturing
ing with the respective full-length cDNAs. The uniformity of
sample loading was veri?ed by ethidium bromide staining of
ribosomal RNA (Loading control).

pound produced by Nicoliana tabacum in response to fungal
elicitation, and it is formed via the isoprenoid pathway from
5-epi-aristolochene. Much of the biosynthetic pathway for
the formation of this compound has been elucidated, except
for the enzyme(s) responsible for the conversion of the allylic
sesquiterpene 5-epi-aristolochene to its dihydroxylated form,

?ed from a cDNA library prepared against mRNA from elici
tor-treated cells using PCR. The PCR fragments were subse

quently used to isolate full-length cDNAs (CYP71D20 (SEQ
ID N012) and D21 (SEQ ID N014), CYP73A27 (SEQ ID
N016) andA28 (SEQ ID N018), CYP82E1 (SEQ ID N0110),

engineered into the yeast (WAT11) cells was induced by a

and CYP92A5 (SEQ ID N0112)), and these in turn were used
to demonstrate that the corresponding mRNAs were all

galactose treatment, followed by isolation of microsomal
preparations. The difference adsorption spectra of
microsomes incubated in the presence (solid lines) and

induced in elicitor-treated cells, albeit with different induc
tion patterns.

absence (broken lines) of carbon monoxide was determined.
FIG. 7 is a series of gas chromatograms of the reaction
products formed upon incubation of microsomes isolated
from WATl 1 yeast cells containing the CYP71D20 expres
sion construct (A and C) or vector control DNA (B and D)
with sesquiterpene substrates. Microsomes isolated from the
indicated yeast lines were incubated with 5-epi-aristolochene

45
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Using an indirect assay, a detailed induction time course of

SEAH activity in elicitor-induced cell cultures was deter
60

acid sequence of Nicotiana tabacum 5-epi-aristolochene (ses

ear monoterpenes, while PaCYP71A1 (A35867) catalyzes

mined relative to that of EAS activity (FIG. 2), the well

characterized sesquiterpene cyclase activity that catalyzes the
formation of 5-epi-aristolochene from FPP (FIG. 1). Using

FIGS. 8A-D provide a sequence comparison of the amino

quiterpene) hydroxylase NtCYP71D20 (SEQ ID N011) with
other plant terpene hydroxylases (SEQ ID NOS139-43).
NrCYP71A5v1 (GenBank accession number CAA70575)
catalyzes the mono-hydroxylation of nerol and geraniol, lin

There now follows a description of the cloning of several
P450s from Nicoliana tabacum. These examples are provided
for the purpose of illustrating the invention, and are not to be
considered as limiting.
Inhibition of the 5-epi-aristolochene to Capsidiol Conversion

by P450 Antagonists

(A and B) or 1-deoxycapsidiol (C and D) in the presence
(solid lines) or absence (dashed lines) of NADPH. The iden
tities of 5-epi-aristolochene, 1-deoxycapsidiol, and capsidiol
were veri?ed by mass spectrometry.

EXAMPLES
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assays for EAS and SEAH, EAS activity is not detectable in
control cell cultures, but is induced signi?cantly within 3
65

hours and reaches its maximal level within 15 to 18 hours of
elicitor-treatment. Similar to the EAS enzyme activity, 5EAH

activity was negligible in control cell cultures. Nonetheless,

